What is Acomplia ?
Accomplia is such a wonder drug that preliminary trials have shown that 33% of people who were put on Acomplia lost 10% of weight and could maintain that for two years. Acomplia also helped to quit smoking and in promoting healthy lipid levels thus protecting the cardiovascular system
A weight loss of 5 to 10% can help in reducing risks of obesity-related diseases and delay/prevent type 2 diabetes in persons with high risk. Obesity is nowadays a very common nutritional disorder owing to today’s stress filled lives in western countries. A person with Body mass index is said to be obese.
As well as keeping you lean, the drug also acts as antismoking drug. This will be of great interest for many smokers as they say they will put on loads of weight if they do (usually young female smokers worry about this the most).
A single pill has been found to stop both food and cigarette cravings enough to help people quit smoking and lose weight, and could also help curb other unhealthy urges. Named Acomplia the drug in one study helped people who were overweight drop an average of 20 pounds and in another doubled the chances that smokers would quit. Acomplia is made by French firm Sanofi-Synthelabo and the company says it could be available as early as 2006. Acomplia contains the active ingredient Rimonabant.
How Acomplia works?
Human’s have nerve receptors in the brain and fat cells which prompt us to overeat or indulge in smoking. Acomplia blocks the signals these receptors give out to the brain thus decreasing the wish to eat more or do more smoking. Overeater’s and addicted smokers have very active receptors of these type which are blocked from informing the brain to carry out a particular operation.
Rimonabant (which will be brought to market as Acomplia) works by blocking the CB1 receptor, one of two receptors found in a newly described physiological system called the Endocannabinoid System (EC System), believed to play a critical role in the regulation of food intake and energy expenditure.
Researchers wondered whether a drug that halted this action might curb appetite, and in 2001, the first animal study was conducted at the National Institute of Alcohol Abuse and Alcoholism in Bethesda, Md.
In the study, genetically altered mice that lacked cannabinoid receptors ate less than their litter mates, even after 18 hours of fasting. When the normal mice were given rimonabant, which blocked their CB1 receptors, the mice reduced their food intake.In 2002, Sanofi-Synthelabo began human testing.
Acomplia works by selectively targeting and blocking the CB1 receptors, helping normalize the over-activation of the EC system and making hunger or cigarette cravings more manageable.
This blocking of signals that control cravings appears to result in weight loss, improvement of cardiovascular/ metabolic risk factors in overweight/obese patients and appears to reduce tobacco dependence without post cessation weight gain in people who smoke.
Advantages and side effects :
Advantages of Acomplia include weight loss, easiness in quitting smoking or reduction in smoking and lowering of cardiovascular risk.
Acomplia was said to be well tolerated in early tests. The only relatively common side effects were mild GI side effects and dizziness, and these were said to be transient.
Acomplia has certain minor side effects. Nausea, headache, irritability and dizziness are certain side effects you should expect when you order Acomplia online. However, these side effects are transient in nature and will go away once your body adjusts to the medication.
Order acomplia online for weight loss and anti smoking drug.
Buy Acomplia online at http://www.rimonabant-acomplia.co.uk – play safe!!
Leave a Reply